These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 27889577

  • 1. Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety.
    Hu K, Sonti S, Glaser ST, Duclos RI, Gatley SJ.
    Nucl Med Biol; 2017 Feb; 45():43-50. PubMed ID: 27889577
    [Abstract] [Full Text] [Related]

  • 2. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 3. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
    Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM.
    BMC Biochem; 2009 May 21; 10():14. PubMed ID: 19460156
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr 21; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
    Thors L, Eriksson J, Fowler CJ.
    Br J Pharmacol; 2007 Nov 21; 152(5):744-50. PubMed ID: 17676056
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST, Gatley SJ, Gifford AN.
    J Pharmacol Exp Ther; 2006 Mar 21; 316(3):1088-97. PubMed ID: 16278311
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.
    Hamtiaux L, Masquelier J, Muccioli GG, Bouzin C, Feron O, Gallez B, Lambert DM.
    BMC Cancer; 2012 Mar 19; 12():92. PubMed ID: 22429826
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, Ueda N.
    Biochim Biophys Acta; 2005 Oct 01; 1736(3):211-20. PubMed ID: 16154384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold.
    Wang L, Yui J, Wang Q, Zhang Y, Mori W, Shimoda Y, Fujinaga M, Kumata K, Yamasaki T, Hatori A, Rotstein BH, Collier TL, Ran C, Vasdev N, Zhang MR, Liang SH.
    ACS Chem Neurosci; 2016 Jan 20; 7(1):109-18. PubMed ID: 26505525
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.
    Darmani NA, McClanahan BA, Trinh C, Petrosino S, Valenti M, Di Marzo V.
    Neuropharmacology; 2005 Sep 20; 49(4):502-13. PubMed ID: 15921709
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK, Kidd SR, Moore SA, Schaus JM, Liu B, Nomikos GG, Felder CC.
    Cell Mol Neurobiol; 2006 Sep 20; 26(4-6):407-23. PubMed ID: 16736384
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B.
    Oncotarget; 2016 Mar 22; 7(12):15047-64. PubMed ID: 26930716
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
    Egertová M, Cravatt BF, Elphick MR.
    Neuroscience; 2003 Mar 22; 119(2):481-96. PubMed ID: 12770562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.